Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

Qpex Biopharma

Oct 25, 2018PR-M10-18-NI-087

Qpex to continue partnership with BARDA with total award up to $132 million

About BARDA

Qpex's partnership with BARDA is funded in whole or in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under OTA number HHSO100201600026C.

AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration

AustinPx

PR-06-26-03Jun 30, 2026

Research Collab

10x Genomics and Cleveland Clinic Collaborate in Diagnostic Applications of Single Cell and Spatial Technologies in Bladder Cancer

10x Genomics

PR-06-26-02Jun 17, 2026

CNS Clinical

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969

Insilico Medicine

PR-06-26-01Jun 17, 2026

Psych R&D

Rebuilding the Psychiatric Drug Discovery Pipeline

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-26-PA-14May 13, 2026

Partnership

The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation

The Solubility Company

PR-05-26-02May 13, 2026

Lab Software

Lab Thread Introduces Unified Lab Software Platform to Streamline Biological Research

Lab Thread

PR-05-26-01May 8, 2026

Microbiome

Zymo Research Launches Fecal Microbiome Discovery Grant to Enable the Next Breakthroughs in Human Health

Zymo Research Corp.

PR-04-26-10Apr 24, 2026

Proteomics

RareCyte Expands Clinical-Scale Spatial Proteomics Portfolio with New Orion Systems and Leadership Appointment

RareCyte

PR-04-26-09Apr 20, 2026

Fluid Management

Introducing CPC Biotech - One Brand Uniting Critical Fluid Management Components

PR-04-26-08Apr 16, 2026

Tariffs

The Intersection of Pharmaceutical Tariffs, Outsourcing, and Investment: Balance is Key

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-04-26-PA-15Apr 15, 2026

Appointment

Dr.Evidence Appoints David Pennington as Chief Executive Officer

Dr.Evidence

PR-04-26-07Apr 9, 2026

Intercellular

Transferring Cytoplasmic Contents and Organelles Between Living Cells

Waseda University

PR-04-26-06Apr 3, 2026

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

My Account

Subscribe for the newsletter

Subscribe for the Newsletter

Mobile Navigation

Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

Qpex to continue partnership with BARDA with total award up to $132 million

Related Content

Bioavailability